Anderson notes that biopharma has been sheltered from tariffs for decades, including during the first Trump administration, however this time around the administration placed tariffs on pharmaceutical ...

While pharmaceutical companies are safe for the time being from country-specific reciprocal tariffs announced by President ...

US-India pharmaceutical and medical device industries navigate Trump's tariff plan, with potential impacts on exports and ...

Drug and medical device makers didn’t oppose Robert F. Kennedy Jr.’s confirmation as health secretary but are speaking up in ...

According to Exports Promotion Council of Medical Devices, India's exports of medical devices to the US stood at $714.38 ...

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 ...

Trial lawyers, especially defense lawyers in the pharmaceutical and medical device arena, strive to ensure that “junk science” stays out of ...

However, in his Wednesday speech, Trump indicated that tariffs on pharmaceutical imports may not be totally off the table.

Lobby groups like AdvaMed and the American Hospital Association have so far failed to get medical devices and critical ...

U.S. tariffs on medical products could significantly impact companies with operational footprints in Ireland, Germany, and ...

First, imposing a 26% tariff on medical devices imported from India will be a sharp escalation from previous tariffs.